Development of a prognostic prediction model based on microRNA-1269a in esophageal cancer

Table 2 Relationship between microRNA-1269a and pathological data

Characteristics	High expression, n = 62	Low expression, n = 63	P value
Age in yr			0.531
< 60	33 (53.2)	30 (47.6)
≥ 60	29 (46.7)	33 (52.3)
Gender			0.77
Female	24 (38.7)	26 (41.3)
Male	38 (61.2)	37 (58.7)
Location			0.8
Upper + middle area	24 (38.7)	23 (36.5)
Lower area	38 (61.2)	40 (63.5)
Histologic grade			0.003
G 1	27 (38.7)	12 (38.7)
G 2 + G 3	35 (38.7)	51 (38.7)
AJCC stage			0.001
Stage I + II	21 (33.9)	53 (84.1)
Stage III + IV	41 (66.1)	10 (15.9)
Tumor stage			0.004
T1 + T2	18 (29.0)	34 (54.0)
T3 + T4	44 (70.0)	29 (46.0)
Lymph stage			0.009
N0	22 (35.5)	37 (58.7)
N1 + N2 + N3	40 (64.5)	26 (41.3)
Metastatic stage			0.011
M0	56 (0.0)	63 (100.0)
M1	6 (100.0)	0 (0.0)

AJCC: American Joint Committee on Cancer; ESCA: Esophageal cancer; G 1: Grade 1, high differentiation; G 2: Grade 2, moderate differentiation; G 3: Grade 3, low differentiation.